Plain-English translation of NCT07199946 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing whether verapamil, a medication commonly used to treat heart and blood pressure conditions, can help preserve the insulin-producing cells in children who were recently diagnosed with type 1 diabetes. The trial will compare the medication to a placebo (inactive pill) to see if this treatment helps children's bodies continue making their own insulin over time. Preserving natural insulin production can make diabetes easier to manage and help prevent serious complications.
When children are first diagnosed with type 1 diabetes, their bodies can still produce some insulin, but this ability gradually fades. If researchers can slow or stop this decline, it could dramatically improve blood sugar control and quality of life. This trial is exploring whether this medication might offer a new way to protect the insulin-producing cells in the critical early months after diagnosis.
You likely qualify if…
You likely don't qualify if…
The study has two parts: a small pilot group of 6 children will first receive the medication openly, and then 30 more children will be randomly assigned to either receive the medication or a placebo for 12 months. You will take the medication by mouth daily at home. Throughout the study, you'll attend regular clinic visits where doctors will check your blood sugar control, measure how much insulin your body is still producing, check for side effects, and monitor your overall health. The study lasts about 2 years total, with close follow-up visits in the first months and then regular check-ins to track how well the treatment is working.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Sweden